CluenexCrane Co. CR
Crane Co. scores good on business quality (6.1 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Crane Co. does
Crane Co manufactures engineered industrial products, selling valves, pumps, and fluid handling systems to commercial and aerospace customers. The company focuses on expanding its specialized manufacturing footprint to capture recurring demand across industrial niches.
- What it does best
Crane turns revenue into free cash flow effectively, generating $381M on $2.6B of sales. Its gross margin of 41.8% beats peer TKR at 32.4%, reflecting pricing power in niche industrial valves.
- The main risk
Net debt sits at $642.0M while total debt reaches $1.1B, creating balance sheet exposure if industrial demand softens and compresses cash generation.
Quality, check by check
Scored against its own industry, from company filings.
Gross margin of 41.8% and operating margin of 17.9% drive a return on equity of 16.2%, though profitability remains constrained by moderate asset efficiency.
An operating margin in the top quartile of its sector at 17.9% highlights proprietary product niches that protect pricing from low-cost rivals.
Revenue grew to $2.6B, maintaining an 8.2% growth rate that builds on consecutive years of top-line expansion from $1.9B in 2023.
Interest coverage sits at 12.9x, making debt servicing manageable alongside $506M in cash and $381M in free cash flow, getting stronger.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
1 sold $220K outside pre-planned sales.
Our sealed record on CR
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Crane Co. scores good on the Cluenex quality check (6.1 of 10), measured against its own industry. Profitability is fair, moat fair, growth steady and financial health strong.
In the last 90 days of SEC Form 4 filings: 1 sold $220K outside pre-planned sales.
Oct 27, 2026, after the close.
See CR today
- Today's verdict on CR, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Crane Co. (CR)”, https://cluenex.com/stocks/cr/, data as of Oct 10, 2026.